Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

CAH stock hub

Cardinal Health, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CAHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

43B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

CAH

In the news

Latest news · CAH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16

P25 12.6P50 18.3P75 33.7

Trailing P/E28.1

P25 15P50 23.3P75 38.5

ROEn/a

P25 -106.6P50 -46.9P75 -3.1

ROIC81

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CAH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

275

Groups with data

Currency

USD

Showing 275 of 275 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000721371
Company name	Cardinal Health, Inc.
Country	United States
Country code	US
Cusip	14149Y108
Employees	57,700
Employees Change	8,800%
Employees Change Percent	18
Enterprise value	$48B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Distribution
Isin	US14149Y1082
Last refreshed	2026-05-10
Market cap	$43B
Market cap category	Large-Cap
Price	$184
Price currency	USD
Rev Per Employee	4,345,493.93x
Sector	Healthcare
Sic	5122
Symbol	CAH
Tags	pharmaceuticals
Website	https://www.cardinalhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.62%
EV Earnings	30.86x
EV Sales Forward	0.17x
EV/EBIT	15.63x
EV/EBITDA	12.02x
EV/FCF	10.94x
EV/Sales	0.19x
FCF yield	10.19%
Forward P/E	15.97x
P/E ratio	28.09x
P/S ratio	0.17x
PE Ratio10 Y	181.09x
PE Ratio3 Y	38.11x
PE Ratio5 Y	35.31x
PEG ratio	0.94x
PS Forward	0.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.22%
EBITDA Margin	1.59%
FCF margin	1.75%
Gross margin	3.76%
Gross Profit	$9.4B
Gross Profit Growth	19.98%
Gross Profit Growth Q	17.66%
Gross Profit Growth3 Y	12.2%
Gross Profit Growth5 Y	6.44%
Net Income	$1.6B
Net Income Growth	-0.13%
Net Income Growth Q	-21.15%
Net Income Growth Years	3%
Net Income Growth3 Y	49.76%
Net Income Growth5 Y	6.2%
Pretax Margin	0.8%
Profit Margin	0.62%
Profit Per Employee	$26,950
Profitable Years	3
ROA	3.6
Roa5y	2.74
ROCE	20.88
ROIC	80.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.23%
Cagr15y	12.75%
Cagr1y	21.02%
Cagr20y	9.29%
Cagr3y	32.36%
Cagr5y	28.8%
Div CAGR10	2.44%
Div CAGR3	1%
Div CAGR5	1%
EPS Growth	2.48
EPS Growth Q	-19.52
EPS Growth Years	3
EPS Growth3 Y	55.43
EPS Growth5 Y	10.85
FCF Growth	78.91%
FCF Growth Q	-39.98%
FCF Growth3 Y	-1.19%
FCF Growth5 Y	22.43%
OCF Growth	69.04%
OCF Growth Q	-37.57%
OCF Growth10 Y	4.57%
OCF Growth3 Y	0.19%
OCF Growth5 Y	20.07%
Revenue Growth	12.8x
Revenue Growth Q	11.05x
Revenue Growth Quarters	5x
Revenue Growth Years	0x
Revenue Growth3 Y	8.07x
Revenue Growth5 Y	9.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$4.71
Assets	$56.7B
Cash	$3.9B
Current Assets	$38.1B
Current Liabilities	$42B
Debt	$8.9B
Debt EBITDA	$2.13
Debt FCF	$2.03
Equity	$-2.7B
Interest Coverage	10.73
Liabilities	$59.4B
Long Term Assets	$18.6B
Long Term Liabilities	$17.4B
Net Cash	$-5B
Net Cash By Market Cap	$-11.58
Net Debt EBITDA	$1.25
Net Debt FCF	$1.14
Tangible Book Value	$-16.5B
Tangible Book Value Per Share	$-70.34
WACC	6.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.91
Inventory Turnover	14.13
Net Working Capital	$-7.2B
Quick ratio	0.42
Working Capital	$-3.9B
Working Capital Turnover	$-83.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.36%
Dividend Growth	1.01%
Dividend Growth Years	1%
Dividend per share	$2.04
Dividend Years	44
Dividend Yield	1.11%
Ex Div Date	2026-07-01
Last Dividend	$0.52
Payout Frequency	Quarterly
Payout Ratio	31.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	216.91%
1Y total return	21.01%
200-day SMA	190.1
3Y total return	131.94%
50-day SMA	209.9
50-day SMA vs 200-day SMA	50over200
5Y total return	254.35%
All Time High	233.6
All Time High Change	-21.38%
All Time High Date	2026-03-02
All Time Low	0.99
All Time Low Change	18,362.85%
All Time Low Date	1984-12-05
ATR	6.1
Beta	0.54
Beta1y	0.2
Beta2y	0.36
Ch YTD	-10.63
High	190.2
High52	233.6
High52 Date	2026-03-02
High52ch	-21.38%
Low	182.9
Low52	137.8
Low52 Date	2025-08-12
Low52ch	33.32%
Ma50ch	-12.51%
Premarket Change Percent	0.93
Premarket Price	$187
Premarket Volume	136
Price vs 200-day SMA	-3.39%
RSI	27.6
RSI Monthly	58.84
RSI Weekly	39.93
Sharpe ratio	0.65x
Sortino ratio	1.31
Total Return	3.47%
Tr YTD	-10.19
Tr15y	505.08%
Tr1m	-13.69%
Tr1w	-5.94%
Tr3m	-18.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	12
Analyst Count Top	3
Analyst Price Target Top	$217
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$2.8
Earnings EPS Estimate Growth	19.15
Earnings Revenue Estimate	62,281,778,424x
Earnings Revenue Estimate Growth	13.49x
Operating Income	$3.1B
Operating Income Growth	27.81
Operating Income Growth Q	17.78
Operating Income Growth3 Y	23.19
Operating Income Growth5 Y	10.33
Operating margin	1.22
Price target	$232
Price Target Change	$26.08
Price Target Change Top	$18.16

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	233,745,620%
Float Percent	99.8%
Net Borrowing	1,143,000,000
Shares Insiders	0.09%
Shares Institutions	90.64%
Shares Out	234,205,855
Shares Qo Q	-0.42%
Shares Yo Y	-2.36%
Short Float	2.52%
Short Ratio	3.53
Short Shares	2.51

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$3.9B
Average Volume	2,078,075.7x
Bv Per Share	-12.05
CAPEX	$-617M
Ch10y	139
Ch15y	312
Ch1m	-13.69
Ch1w	-5.94
Ch1y	19.66
Ch20y	169.3
Ch3m	-18.85
Ch3y	120.7
Ch5y	215.8
Ch6m	-9.83
Change	-0.88%
Change From Open	-0.92
Close	185.3
Days Gap	0.04
Depreciation Amortization	924,000,000
Dollar Volume	598,834,166.4
Earnings Date	2026-04-30
Earnings Time	bmo
EBIT	$3.1B
EBITDA	$4B
EPS	$6.54
F Score	6
FCF	$4.4B
FCF EV Yield	9.14x
FCF Per Share	$18.72
Financing CF	-449,000,000
Fiscal Year End	June
Founded	1,979
Goodwill	11,415,000,000
Income Tax	$456M
Investing CF	-3,934,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2001-04-23
Last Split Type	Forward
Last10k Filing Date	2025-08-12
Lynch Fair Value	$40.54
Lynch Upside	-77.92
Ma150	202.7
Ma150ch	-9.4%
Ma20	202.1
Ma20ch	-9.14%
Net CF	611,000,000
Next Earnings Date	2026-08-11
Open	185.4
Optionable	Yes
P FCF Ratio	9.81
P OCF Ratio	8.6
Payment Date	2026-07-15
Position In Range	10.58
Post Close	183.7
Postmarket Change Percent	0.34
Postmarket Price	$184
Ppne	2,928,000,000
Pre Close	185.3
Price Date	2026-05-08
Price EBITDA	$10.77
Relative Volume	1.57x
Revenue	250,735,000,000x
SBC By Revenue	0.18x
Share Based Comp	462,000,000
Tax By Revenue	0.18x
Tax Rate	22.75%
Tr20y	491.5%
Tr6m	-9.39%
Us State	Ohio
Volume	3,260,736
Z Score	4.99

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

CAH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$2.04 annual per share

Payout ratio

+31.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+1.0%

1 consecutive years of growth

Total shareholder yield

+3.5%

Next ex-dividend date: 2026-07-01

Performance

CAH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CAH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.6%

Float: +99.8% of shares outstanding

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CAH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

27.6

Below 30: short-term oversold

Price vs 200-day MA

-3.4%

50/200-day relationship not available

Beta (5Y)

0.54

Less volatile than the market

Sharpe ratio

0.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CAH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CAH stock rating?

Cardinal Health, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CAH analysis?

The full report lives at /stocks/CAH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CAH?

The latest report frames CAH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CAH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.